Nathan Rich
Stock Analyst at Goldman Sachs
(1.01)
# 3,613
Out of 4,749 analysts
89
Total ratings
33.87%
Success rate
-10.66%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $16.60 | +26.51% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $170.90 | +14.69% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $19.76 | +51.82% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $8.26 | -3.15% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $20.52 | -14.72% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $293.23 | +31.30% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $12.03 | +16.38% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical | Maintains: Neutral | $10 → $11 | $17.73 | -37.96% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $219.11 | +2.69% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $422.05 | +54.01% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $30 | $30.95 | -3.07% | 5 | Dec 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $56.48 | +55.81% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $15.39 | -22.03% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $80.00 | +6.25% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $11.28 | -2.48% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $310.41 | +7.92% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $542.49 | -1.38% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $16.60
Upside: +26.51%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $170.90
Upside: +14.69%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $19.76
Upside: +51.82%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $8.26
Upside: -3.15%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $20.52
Upside: -14.72%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $293.23
Upside: +31.30%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $12.03
Upside: +16.38%
Teva Pharmaceutical
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $17.73
Upside: -37.96%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $219.11
Upside: +2.69%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $422.05
Upside: +54.01%
Dec 1, 2023
Maintains: Neutral
Price Target: $35 → $30
Current: $30.95
Upside: -3.07%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $56.48
Upside: +55.81%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $15.39
Upside: -22.03%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $80.00
Upside: +6.25%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $11.28
Upside: -2.48%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $310.41
Upside: +7.92%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $542.49
Upside: -1.38%